一种生白口服液的含量测定方法
By using high-performance liquid chromatography and solid-phase extraction technology, the problem of determining multiple components in Shengbai oral liquid was solved, enabling comprehensive quality control and evaluation of Shengbai oral liquid and ensuring the accuracy and reliability of the determination results.
Patent Information
- Authority / Receiving Office
- CN · China
- Patent Type
- Patents(China)
- Current Assignee / Owner
- MONYAN PHARMACEUTICAL CO LTD
- Filing Date
- 2023-07-21
- Publication Date
- 2026-07-17
AI Technical Summary
In the existing technology, the content determination method of Shengbai oral liquid cannot comprehensively and objectively reflect the intrinsic quality of its complex material system. In particular, the determination of the 11 Chinese herbal medicine components is too simple and is not applicable to compounds containing sugars and highly polar compounds.
High-performance liquid chromatography (HPLC) was used to simultaneously determine multiple components in Epimedium, Psoralea corylifolia, and Glycyrrhizic acid. The samples were purified by solid-phase extraction, and appropriate HPLC analysis conditions were selected to determine the content of icariin C, epimedin, psoralen, and ammonium glycyrrhizate in Shengbai oral liquid.
This enables efficient, accurate, and comprehensive quality control and evaluation of Shengbai oral liquid, ensuring the accuracy and reliability of the test results.
Smart Images
Figure FT_1 
Figure FT_2 
Figure FT_3